Point mutation in p14 -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma.

Authors:
L Anderson
L Anderson
USA; New York University Langone Medical Center Child Study Center
United States

Br J Dermatol 2018 Apr 19;178(4):e263-e264. Epub 2018 Feb 19.

Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT) at Translational Research Institute, Woolloongabba, Queensland, Australia.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.16275DOI Listing
April 2018
3 Reads

Publication Analysis

Top Keywords

cdkn2a causing
4
1β cdkn2a
4
causing familial
4
familial melanoma
4
melanoma astrocytoma
4
-specific exon
4
exon 1β
4
mutation p14
4
point mutation
4
p14 -specific
4
melanoma
1
p14
1
astrocytoma
1
familial
1
-specific
1
1
point
1
cdkn2a
1
causing
1
exon
1

Similar Publications

Novel and recurrent p14 mutations in Italian familial melanoma.

Clin Genet 2010 Jun 4;77(6):581-6. Epub 2010 Feb 4.

Medical Genetics, Sapienza University, S. Camillo-Forlanini Hospital, Rome, Italy.

CDKN2A and CDK4 are the only known high-penetrant genes conferring proneness to cutaneous melanoma. The CDKN2A locus consists of four exons and encodes several alternate transcripts, two of which are p16(INK4a) and p14(ARF), and originate from different open reading frames. Exon 1alpha is specific for p16(INK4a), while exon 1beta characterizes p14(ARF). Read More

View Article
June 2010

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Hum Mol Genet 2001 Jan;10(1):55-62

ICRF Genetic Epidemiology Division, ICRF Clinical Centre in Leeds, Cancer Genetics Building, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.

The melanoma-astrocytoma syndrome is characterized by a dual predisposition to melanoma and neural system tumours, commonly astrocytoma. Germline deletions of the region on 9p21 containing the CDKN2A and CDKN2B genes and CDKN2A exon 1beta have been reported in kindreds, implicating contiguous tumour suppressor gene deletion as a cause of this syndrome. We describe a family characterized by multiple melanoma and neural cell tumours segregating with a germline deletion of the p14(ARF)-specific exon 1beta of the CDKN2A gene. Read More

View Article
January 2001

Germline mutation of ARF in a melanoma kindred.

Hum Mol Genet 2002 May;11(11):1273-9

University of Manchester Department of Medical Genetics and Regional Genetic Service, Central Manchester Healthcare Trust, St. Mary's Hospital, Manchester, M13 OJH, UK.

Familial melanoma predisposition is associated with germline mutations at the CDKN2A/ARF locus in up to 40% of families. The exact role of the two proteins encoded by this complex locus in this predisposition is unclear. Most mutations affect either CDKN2A only or products of both genes. Read More

View Article
May 2002

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Am J Pathol 2001 Aug;159(2):661-9

Departments of Neurosurgery and Neuropathology, University of Bonn Medical Center, Bonn, Germany.

We investigated 67 meningothelial tumors (20 benign meningiomas, 34 atypical meningiomas, and 13 anaplastic meningiomas) for losses of genetic information from chromosome arms 1p and 9p, as well as for deletion, mutation, and expression of the tumor suppressor genes CDKN2A (p16(INKa)/MTS1), p14(ARF), CDKN2B (p15(INK4b)/MTS2) (all located at 9p21) and CDKN2C (1p32). Comparative genomic hybridization and microsatellite analysis showed losses on 1p in 11 anaplastic meningiomas (85%), 23 atypical meningiomas (68%), and 5 benign meningiomas (25%). One atypical meningioma with loss of heterozygosity on 1p carried a somatic CDKN2C mutation (c. Read More

View Article
August 2001